Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans. uri icon

authors

  • Zhang, Pengyue
  • Hou, Yuan
  • Tu, Wanzhu
  • Campbell, Noll
  • Pieper, Andrew A
  • Leverenz, James B
  • Gao, Sujuan
  • Cummings, Jeffrey
  • Cheng, Feixiong

publication date

  • January 1, 2022